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Abstract
Background: The involvement of collateral blood flow/fluid shear stress, nitric oxide (NO), and macrophages
during collateral growth (arteriogenesis) is established, but their interplay remains paradoxical.
Methods: In order to further elucidate the “fluid shear stress/NO/macrophage” paradox, we investigated the time
course of collateral blood flow (using a Doppler flow probe) and NOS expression (immunohistochemistry, Western
blot) in growing rat collateral vessels after femoral artery occlusion and their impact on macrophage recruitment
and collateral proliferation (immunohistochemistry, angiographies).
Results: (values are given as mean ± standard error of mean) Early after occlusion, collateral blood flow was
significantly reduced (pre- 90.0 ± 4.5 vs. post-occlusion 62.5 ± 5.9 μl/min; p < 0.01), and local inducible NOS (iNOS)
and endothelial NOS (eNOS) expression were down-regulated (expression in % of non-occluded: eNOS 49.4 ±
11.8% and iNOS 54.5 ± 7.9% vs. non-occluded at 12 h after occlusion; p < 0.03). An artificial rise (induced by a
peripheral vasodilatation) of the initially decreased collateral blood flow back to pre-occlusion levels reduced
collateral macrophage recruitment (macrophages per collateral section: post- 42.5 ± 4.4 vs. artificial pre-occlusion
27.8 ± 2.0; p < 0.05) and diminished collateral proliferation (proliferative index: post- 0.54 ± 0.02 vs. artificial pre-
occlusion 0.19 ± 0.04; p < 0.001) significantly 72 h after femoral artery occlusion.
Conclusions: We propose the following resolution of the “fluid shear stress/NO/macrophage” paradox: Collateral
blood flow and NOS expression are initially reduced during arteriogenesis allowing macrophages to accumulate
and therewith enhancing collateral proliferation. After homing of macrophages (24 h after occlusion), collateral
blood flow and NOS expression recover in order to join the effects of macrophages for restoring blood flow.
Background
Investigations conducted during the last decade have
demonstrated that growth of collateral arteries involves
pre-existing arteriolar anastomoses [1]. This phenom-
enon is restricted to certain vessels within a region and
occurs largely outside ischemic territories [2]. These
characteristics are distinguished from angiogenesis, the
sprouting of capillaries within ischemic territories, and
vasculogenesis, that is, the in situ growth of vascular
structures from immature precursor cells [3]. The term
arteriogenesis has therefore been established for the
remodeling process of pre-existing arteriolar shunts into
large conductance vessels. It is now widely accepted that
flow dependent forces (e.g. fluid shear stress, defined as
the viscous drag of flowing blood on the endothelial lin-
ing) and macrophage accumulation play a pivotal role
during that process [4]. Below, we describe these major
components of arteriogenesis.
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As compared to circumferential wall stress, fluid shear
stress (FSS) is a rather weak force and mostly acts on
endothelial cells. After arterial occlusion, a steep pres-
sure gradient develops between proximal and distal
areas of conductance vessels. According to Ohm’sl a w ,
t h ei n c r e a s ei np r o x i m a lt od i s t a lp r e s s u r eg a pc o u l d
only be explained by an increase of flow velocities in
pre-existing shunts if resistances and diameters
remained the same. Elevated collateral blood flow
directly results in elevated collateral fluid shear stress
[4,5]. Artificial elevations of collateral flow using arterio-
venous shunts lead to vascular remodeling processes
very similar to collateral growth [6].
Monocytes/Macrophages
Early macrophage recruitment during maximal prolifera-
tion is another hallmark of collateral artery growth and
was first described in dog heart collateral vessels [7].
Subsequent investigations in the rabbit and rat hind
limb revealed that macrophage recruitment occurred
very early during collateral growth and paralleled maxi-
mal proliferation of endothelial and smooth muscle cells
[1,8]. Several studies demonstrated that enhancement of
macrophage recruitment and survival accelerated collat-
eral growth. In this context, the chemokine MCP-1
(monocyte chemotactic protein-1), is a strong chemotac-
tic factor for monocytes/macrophages, and a potent sti-
mulator of arteriogenesis [9]. Animals deficient in the
MCP-1 receptor CCR2 (C-C chemokine receptor 2)
demonstrated reduced arteriogenic potential [10], under-
scoring the importance of MCP-1 in arteriogenesis.
Macrophages secrete the majority of growth factors dur-
ing maximal proliferation [9,11].
Nitric oxide
Even if recent studies provide strong evidence that arter-
iogenesis requires nitric oxide (NO) [12], its specific role
during that process remains elusive.
On one hand, it was demonstrated that increased
blood flow leads to higher nitric oxide (NO) produc-
tion by the endothelium via stimulation of endothelial
nitric oxide synthase (eNOS) expression [13] and acti-
vation [14]. Indeed, transcripts for eNOS and inducible
nitric oxide synthase (iNOS) were found to be up-
regulated on both transcriptional and translational
levels during arteriogenesis [4]. Furthermore, Nomega-
nitro-L-arginine-methyl-ester (L-NAME), a potent
NOS inhibitor, markedly inhibited the effects of
increased FSS [15] on arteriogenesis. In addition, NO
enhances proliferation and migration of endothelial
cells in vitro [16] and transgenic mice lacking the
eNOS showed reduced angiogenic and arteriogenic
capabilities [17,18].
On the other hand, NO reduces MCP-1 expression in
macrophages and endothelial cells [19,20] and leads to
decreased expressions of cell adhesion molecules such
as CD11, CD18, VCAM-1 (vascular cell adhesion mole-
cule-1), and ICAM-1 (intercellular adhesion molecule-1)
[21,22], counteracting an adhesion of monocytes to the
activated endothelial lining. Furthermore, macrophage
accumulation occurs under low rather than elevated
flow [23] challenging the hypothesis that increased FFS
promotes arteriogenesis.
The shear stress/nitric oxide/macrophage paradox
Thus, the effect of increased flow (fluid shear stress) on
NO expression and monocyte recruitment in the con-
text of arteriogenesis appears paradoxical: On the one
hand, elevated blood flow leads to increased local levels
of NO, which has been shown to promote collateral
growth in several studies [12,24]. At the same time,
increased flow and NO levels impedes monocyte hom-
ing and macrophage accumulation, likewise critical steps
during collateral growth. For example, macrophages and
monocytes accumulate during collateral growth, suggest-
ing an important role during collateral proliferation.
In the present study we provide a possible explanation
for this paradox and hypothesize that a very early phase
of collateral growth is characterized by low collateral
blood flow conditions, allowing macrophages to adhere,
and thus, enhance collateral proliferation.
Methods
Animal model
A rat model of peripheral artery insufficiency with uni-
lateral femoral artery occlusion was used as described
previously [1]. Experiments were conducted on 103
male Spraque Dawley rats weighting 350 - 450 g. All
surgical procedures were performed under general
anesthesia induced by CO2/O2 inhalation and continued
by intra-peritoneal injections of ketamin (100 mg/kg
bodyweight; Atarost GmbH & Co, Twistringen, Ger-
many) and xylazin 2% (5 mg/kg bodyweight; Bayer Vital
GmbH, Leverkusen, Germany). Either MCP-1 (450 ng/
ml in PBS) or PBS (phosphate-buffered saline as vehicle)
was administered directly into the collateral circulation
via osmotic mini pumps (2 ml model, 10 μl/h for 7 d,
Alzet, Palo Alto, USA). The non-specific NO-synthase
inhibitor L-NAME (Sigma-Aldrich, St. Louis, USA) was
given through the drinking water, which was available
fresh daily beginning 2 d before surgical procedures and
continued throughout the whole study (7 d). Each rat
received 65-70 mg L-NAME per kg and per day. Rats of
the non-L-NAME groups received ordinary tap drinking
water. The investigation conforms with the Guide for
the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication
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according to section 8 of the German Law for the
Protection of Animals and was approved by the local
ethic committee (TV No. 5402, Behörde für Umwelt
und Gesundheit der Freien Hansestadt Hamburg,
18.09.2002).
Experiments on the early phase (0 - 72 h after initiation
of collateral growth, Figure 1A + B)
Western blot analyses
In order to examine temporal patterns of the expression
level of NO producing enzymes in collateral vessel walls
we performed quantitative Western blot analyses at three
different time points (12 h, 24 h, 72 h) after initiation of
arteriogenesis. Fifteen rats were included in these ana-
lyses. Main collateral vessels (rudimental ischiadic
arteries) from femoral occluded and non-occluded hind
limbs were carefully prepared and liberated from all
excess tissue including surrounding nerves, veins, and
fibrous tissue in cold PBS. The samples were frozen and
homogenized in liquid nitrogen. The pulverised tissue
was vortexed with ice-cold homogenization buffer and
centrifuged at 3000 × g for 5 min to remove insoluble
material. Sodium dodecylsulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) was performed in 10% slab
gels and transferred electrophoretically onto nitrocellu-
lose membranes using a Bio-Rad Minigel System
(Bio-Rad, Hercules, USA). Each lane was then loaded
12 h 72 h 24 h
NOS expression
GTN
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proliferation
perfusion
BrdU
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L-NAME
BrdU
MCP-1
7 d
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angiographies
C
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Figure 1 Experimental set-up. demonstrated on a post-mortem angiogram (7 d after femoral artery occlusion).
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binding sites were then saturated by immersing the
membranes for 2 h in the appropriate blocking buffer (in
accordance to data sheet). Then, membranes were incu-
bated for another 2 h with the primary monoclonal anti-
bodies [eNOS and iNOS (BD Transduction Laboratories,
San Jose, USA) and a-actinin (Sigma-Aldrich, St. Louis,
USA)], all applied antibody dilutions, blocking and wash-
ing buffers and secondary antibodies were used in accor-
dance to the appropriate data sheets). Membranes were
then washed trice in wash buffer and subsequently incu-
bated for 1 h with peroxidase labelled anti-rabbit or anti-
mouse IgG antibodies (VectorL a b s ,B u r l i n g a m e ,U S A ;
dilution 1:10000). Membranes were processed with the
enhanced chemiluminescence (ECL) Western blotting
detection system (GE Healthcare Europe GmbH,
München, Germany). The obtained X-ray-pictures were
scanned and evaluated densitometrically by using Scan-
Pack software (Biometra, Göttingen, Germany). All bands
were standardized against a-actinin.
Collateral blood flow measurements
Because NOS expression levels are blood flow/shear
force dependent, our NOS expression data needed to be
correlated to collateral blood flow changes during arter-
iogenesis. Eighteen rats were included in these analyses.
A perivascular flowprobe (Transonic Systems Inc.,
Ithaca, USA) was positioned at the stem zone of the
remnant of the ischiadic artery which surfaces below the
gluteal muscle together with the ischiadic nerve and is
easily accessible at this part (Figure 2). As demonstrated
previously this vessel becomes the main collateral vessel
after femoral artery occlusion in the rat hind limb [1].
Previously published corrosion casts from the rat’s hind-
limb (see [1]) and post-mortem angiographies (see Fig-
ure 2) clearly showed that it possesses only a few side
branches until it re-anastomoses with the popliteal
artery. Thus, flow measured at the stem of the vessel
(which is easily accessible in the gluteal sulcus between
the gluteal muscle and the head of the triceps femoris
muscle) reflects closely the flow encountered in the
mid-zone region of the growing collateral vessel. Using
wide beam ultrasonic illumination, the Transonic flow-
meter subtracts the downstream from the upstream
transit times. The difference in the integrated transit
times is a measure of true volume flow and expressed in
microliter per minute (μl per min). Blood flow velocity
in the main collateral vessel was measured at resting
conditions before surgical procedures and directly after
femoral artery occlusion. To further investigate the
effect of an initially increased flow on collateral growth,
we administered the NO donor GTN (glyceryl trinitrate)
into the distal stump of the occluded femoral artery to
break down the increased peripheral resistance. In order
to do so, a third blood flow measurement 3 to 10 min
after a peripheral intra-arterial (via a catheter placed in
the distal stump of the occluded femoral artery)
site of the 
occlusion
rudimental 
ischiadic artery 
(main collateral 
vessel)
internal iliac artery
external iliac artery
GTN administration 
site
popliteal artery
site of flow probe 
position
Figure 2 Experimental set-up. from short-term (early phase) experiments (A + B) from 0 - 72 h and from mid-term (later phase) experiments
(C) 7 d after femoral artery occlusion.
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(Nitrolingual infus; Pohl Boskamp, Hohenlockstedt, Ger-
many) took place. Repeated measurements of blood flow
at later time points could not be obtained due to surgi-
cally induced tissue edema and fibrosis and the inability
to replace the Doppler probe.
Determination of macrophage accumulation
For the assessment of macrophage accumulation, we
used two different antibodies against rat macrophage
antigens that have been validated in numerous studies
[25,26]. We used ED2 (the rat CD163 cell surface glyco-
protein; Serotec, Düsseldorf, Germany) and KiM2R
(Bachem, Peninsula, USA) to stain for mature macro-
phages in rat tissue. Markers for immature macrophages
(ED2/CD169 and TRPM-3) have been compared in a
recent study by our group and yield similar results [25],
and were therefore not applied. We conducted analyses
to assess macrophage accumulation, proliferation, and
tissue perfusion on the same 10 rats. Cryostat acetone
fixed sections (7 μm) were incubated with the primary
antibody followed by incubation with peroxidase
coupled goat-anti-mouse (Dianova GmbH, Hamburg,
Germany). Revelation was performed using amino-ethyl-
carbacyl in sodium acetate (0.1 M, pH 4.8). Negative
controls were obtained for every staining procedure by
omitting the first antibody or by using an isotype con-
trol. Controls were negative for all immunohistochem-
ical stainings presented in this study.
Determination of proliferative index
Along with the macrophage accumulation, we also
investigated collateral proliferation. The same 10 rats
from the monocyte accumulation analyses (see above)
were included. Proliferation index was assessed using
the “5-Bromo-2’-desoxy-uridine Labeling and Detection
Kit 2” (Roche Diagnostics GmbH, Mannheim, Ger-
many), a Cy-2 conjugated goat-anti-mouse IgG (Dianova
GmbH, Hamburg, Germany) antibody and a 0.001%
propidium iodide solution as nuclear staining (Sigma-
Aldrich, St. Louis, USA) as described previously [1]. In
order to quantify monocytes, pictures were taken from 4
to 5 cryo sections of 3 collateral mid-zone segments.
The proliferative index was calculated as number of
BrdU (5-Bromo-2’-desoxy-uridine) positive nuclei (green
fluorescence) divided by the total number of nuclei (red
7-Amino-actinomycin D fluorescence).
Microsphere analyses
To assess collateral-dependent tissue perfusion, fluores-
cent microsphere analyses were conducted, using the
same 10 rats as in the monocyte accumulation analyses
(see above). We thus followed a protocol used and eval-
uated in previous studies [27]. A thoracotomy was per-
formed and ultrasonicated red fluorescent microspheres
(15 μm, Molecular Probes, Invitrogen Corporation,
Carlsbad, USA) were injected in the left ventricle.
Microspheres were counted manually by a blinded
observer in 70 μm frozen sections from the soleus mus-
cle of both legs (femoral occluded vs. non-occluded). A
total of at least 20 microspheres were counted in each
slide. Kidneys served as reference organs proximal to
the occlusion site.
Experiments on the later phase (7 d after initiating of
collateral growth, Figure 1C)
We functionally investigated the interdependency of
macrophage recruitment and NO availability (experi-
mental set-up from Figure 1C) during collateral growth
via a combination of enhanced macrophage recruitment
(MCP-1 infusion) and NO antagonism (L-NAME
administration). Fifty-nine rats were included in these
analyses (31 rats for the macrophage accumulation and
proliferation analyses and 28 rats for the angiographic
experiments). Either MCP-1 or PBS was administered
directly into the collateral circulation via osmotic mini
pumps. The non-specific NO-synthase inhibitor L-
NAME was given through the drinking water, which
was available fresh daily beginning 2 d before surgical
procedures. Determination of macrophage accumulation
and proliferative index was performed as described
above; post-mortem angiographies are described below.
Post-mortem angiographies
Post-mortem angiographies were obtained as described
previously [1,2]. In brief, 12 g of gelatin (Sigma-Aldrich,
St. Louis, USA) was dissolved in 100 ml of heated dis-
tilled water under continuous steering. Afterward, 60 g
of barium sulfate (Merck KGaA, Darmstadt, Germany)
was added. Animals were anesthesized again, anticoagu-
lated, and the aorta was cannulated. Subsequently, ani-
mals were bled and immersed in water warmed to 37°C.
After rinsing the lower part of the body with saline
(37°C, at 80-100 mm-Hg), the contrast medium was
infused with a pressure of 150-180 mmHg until filling
of the distal femoral stump was observed. The animals
were immediately placed on crushed ice in order to
allow the contrast medium to harden under continuous
pressure. Before obtaining the angiographies, the rats
were embedded in gelatin (Sigma-Aldrich, St. Louis,
USA) to fix the animal in order to obtain an equili-
brated thickness for X-ray penetration. X-ray pictures
were taken in a X-ray chamber (Model 43855D, Faxi-
tron X-Ray LLC, Lincolnshire, USA) using single paper
wrapped films (X-OMAT MA 13 × 18 cm, Kodak
GmbH, Stuttgart, Germany) that were exposed to 30 kV
for 6 min. Pictures were taken at two different angles in
order to allow stereoscopical analysis of vessel architec-
ture. Identification and counting of collateral arteries
were performed by using a stereoscope allowing three
dimensional identification of stem, mid-zone, and re-
entry regions of the collateral vessels.
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Data are represented as mean ± standard error of mean
(SEM). Statistical comparisons between groups were
performed by using analysis of variance (ANOVA). Bon-
ferroni corrections were employed for inter-group com-
parisons. P-values below 0.05 were considered
significant.
Results
Experiments on the early phase (0 - 72 h after initiation
of collateral growth, Figure 1A + B)
To examine the level of NO producing enzymes in col-
lateral vessel walls, quantitative Western blot analyses of
NOS expression were performed at different time points
after initiation of arteriogenesis (experimental set-up
from Figure 1A). As shown in Figure 3, the expression
of the NOS was initially (12 h post-occlusion) down-
regulated compared to expression levels in non-femoral
occluded pre-existing collaterals (p < 0.03 vs. non-
occluded). 24 h post-occlusion, the expression of both
eNOS and iNOS then exceeded the corresponding levels
in non-occluded animals by almost 50% (p <0 . 0 3v s .
non-occluded). 72 h after occlusion, eNOS and iNOS
expression did not differ between occluded and non-
occluded animals.
Blood flow in the main collateral vessel was 90.0 ± 4.5
μl/min at resting conditions (Figure 4). After acute
femoral artery occlusion, blood flow significantly
decreased by almost one-third. An acute peripheral,
intra-arterial application of 500 μg GTN into the distal
stump of the occluded femoral artery (experimental set-
up from Figure 2) restored collateral blood flow to pre-
occlusion levels after 3 min.
In order to assess the functional impact of the initial
collateral flow depression on macrophage accumulation
and collateral proliferation, initial blood flow levels were
artificially elevated via infusion of GTN (experimental
set-up from Figure 1B). Chronic GTN infusion (over
72 h) significantly reduced the number of pericollateral
ED2 positive macrophages by more than one-third
(Figure 5A + B and Figure 6A).
This reduced number of macrophages surrounding
collateral vessels (72 h after occlusion with ongoing
GTN supply) was accompanied by a reduction of collat-
eral proliferation (Figure 5C + D and Figure 6B). Con-
tinuous GTN application decreased proliferative index
(PI) by almost two-thirds.
To assess collateral-dependent tissue perfusion, fluor-
escent microsphere analyses were performed. Relative
perfusion of ischemic vs. non-ischemic limbs (soleus
muscle) 72 h after femoral artery occlusion remained
equal in chronic GTN- or non-GTN-treated rats (Figure
6C).
Experiments on the later phase (7 d after initiating of
collateral growth, Figure 1C)
Chronic MCP-1 treatment led to a higher macrophage
accumulation around main collateral vessels as com-
pared to the vehicle (phosphate-buffered saline, PBS,
treated) group (Figure 7A). Likewise, chronic L-NAME
treatment enhanced the number of pericollateral macro-
phages in the PBS as well as in the MCP-1 group. Con-
sistently, MCP-1 significantly increased proliferation in
collateral vessels (Figure 7B). However, NO antagonism
(L-NAME) had no effect on collateral proliferation
neither in PBS nor in MCP-1 treated animals. Chronic
oral L-NAME treatment led to decreased scores of
angiographically visible collateral vessels 7 d after
femoral artery occlusion (Figure 7C), whereas chronic
MCP-1 administration significantly enhanced collateral
growth reflected in a larger amount of vessels in the
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Page 6 of 11collateral network. This positive effect of MCP-1 could
not be antagonized by L-NAME treatment.
Discussion
The cardinal paradox of the arteriogenesis hypothesis on
the initiation of collateral growth was that monocyte
accumulation, a crucial step in this process, occurred
primarily under low rather than high blood flow condi-
tions [22,23]. However, collateral blood flow/FSS was
thought to be elevated during the entire build-up of col-
lateral vessels. Thus far, experimental data on the regu-
lation of blood flow in collateral vessels was missing. In
this study, we present a possible solution to this “FSS/
NO/macrophage” paradox during collateral growth.
Our study demonstrates that collateral growth is a
complex process characterised by a sequence of distinct
steps, beginning with an early phase between 0 and 12 h
after initiation. This phase is characterized by low collat-
eral flow conditions (Figure 4) and a rather low local
NO concentration (Figure 3), allowing macrophages to
adhere to the endothelium and to migrate through the
collateral vessel wall. A second phase between 12 and
24 h after initiation is characterized by elevated
collateral flow and increased NO availability (Figure 3).
Collateral proliferation might be set off during this
phase. Once migrated, macrophages need a certain
degree of NO concentration and elevated flow during
this stage of arteriogenesis to differentiate and prolifer-
ate locally (Figure 7B).
Our analyses demonstrated that the expression of
NOS was significantly down-regulated 12 h post-occlu-
sion (Figure 3), correlating with initially increased
monocyte/macrophage recruitment [22,23], but rose sig-
nificantly beyond expression levels in non-occluded con-
trol animals within 24 to 72 h post-occlusion. Based
upon these initial findings, we hypothesize that collateral
flow and local NO production were initially decreased in
collateral arteries, allowing the recruitment of circulating
cells, which can differentiate locally during the following
days. To assess this hypothesis, we measured blood flow
directly in the stem region of the main collateral artery
in the rat hind limb (rudimental ischiadic artery) via a
transonic flow probe. In agreement with our hypothesis,
flow velocities decreased acutely after femoral artery
occlusion. Interestingly, a previous study published by
our group provided a potential explanation for this
A B
C D
Figure 5 A + B, Immunohistochemical detection of resident macrophages. in the absence (panel A; occlusion) and presence (panel B;
occlusion + GTN) of continuous, peripheral GTN infusion (10 μg/h over 72 h) 72 h after femoral artery occlusion, 20× magnification. C+D ,
Fluorescence immunohistochemical detection of BrdU-incorporated nuclei (green) in the absence (panel C; occlusion) and presence (panel
D; occlusion + GTN) of continuous, peripheral GTN infusion (10 μg/h over 72 h) 72 h after femoral artery occlusion; 20× magnification, 7-Amino-
actinomycin D nuclear stain (red fluorescence).
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increase in peripheral resistance directly after femoral
artery occlusion. This increase in peripheral resistance
could explain why the flow remains rather low, despite
an increase of the pressure gradient across the collateral
circulation.
An acute GTN (a strong vasodilator reducing periph-
eral resistance) infusion blunted this initial decrease of
flow in the collateral vessel (Figure 4). An ongoing infu-
sion of GTN during the first 3 d after femoral artery
occlusion (time period of maximal macrophage accumu-
lation) decreased macrophage accumulation and collat-
eral proliferation (Figure 6A + B). These findings indeed
support the notion that the initial decrease of flow in
collateral vessels is important for collateral macrophage
accumulation and, at the same time, for collateral
proliferation.
During the later phase of collateral growth, local acti-
vation of initially immigrated cells might either be trig-
gered by paracrine mechanisms of the FSS activated
endothelium or via tensile forces. These hypotheses are
supported by the observation that most proliferation of
cells occurs in the direct vicinity of collateral vessels [1].
Because the number of pericollateral macrophages and
collateral proliferation was decreased in the “occlusion +
GTN” (Figure 6A + B) as compared to “occlusion with-
out GTN” group, we also expected to find a reduced
collateral-dependant perfusion. However, finding no
substantial difference in tissue perfusion between both
groups might be explained by the following: Firstly, the
collateral-dependant peripheral tissue perfusion (soleus
muscle) is, in fact, reduced due to less pericollateral
macrophages, and thus, less proliferation of the
upstream lying collaterals, but the effect is abolished by
a GTN-induced peripheral vasodilatation. Actually, the
fact that collateral-dependant perfusion is not reduced
could be an indirect hint that GTN was effective for
72 h and that nitrate tolerance was less likely to have
occurred. Secondly, the effect of an enhanced tissue per-
fusion in the “occlusion” group (due to enhanced collat-
eral proliferation) only occurs on physical activity (when
maximal collateral flow is demanded) and not, as in our
case, under resting conditions.
After our initial experiments, revealing reduced collat-
eral blood flow and NO availability 12 h after femoral
artery occlusion, but increased flow and NO availability
thereafter, we administered L-NAME in order to inhibit
this early collateral NO peak (occurring 24 h after
occlusion). The late phase (chronic) experiments were
conducted to investigate the mid- or long-term effects
of the now modulated early phase. In order to do so, we
assessed the impact of chronic NOS inhibition (oral L-
NAME administration) and macrophage chemotaxis
(intracollateral MCP-1 administration) on macrophage
accumulation and collateral proliferation as well as on
angiographically visible collaterals.
MCP-1 alone led to a late (7 d after femoral artery
occlusion; Figure 7A) enhanced number of pericollateral
macrophages and therewith to an increased collateral
proliferation (Figure 7B) and a larger amount of visible
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Figure 6 A, Quantification of resident macrophages.p e r
collateral section in the absence (occlusion) and presence
(occlusion + GTN) of continuous, peripheral GTN infusion (10 μg/h
over 72 h) 72 h after femoral artery occlusion, *p < 0.05 vs.
occlusion. B, Quantification of proliferation in the absence
(occlusion) and presence (occlusion + GTN) of continuous,
peripheral GTN infusion (10 μg/h over 72 h) 72 h after femoral
artery occlusion, *p < 0.001 vs. occlusion. C, Quantification of
collateral-dependent tissue perfusion in the absence (occlusion)
and presence (occlusion + GTN) of continuous, peripheral GTN
infusion (10 μg/h over 72 h). Ischemic limb perfusion 72 h after
femoral artery occlusion was expressed as a ratio of fluorescent
microsphere counts in ischemic soleus muscle and related to non-
femoral occluded leg (set as 1).
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Page 8 of 11collaterals (Figure 7C). These results are in line with
previous publications [1,8,9]. L-NAME alone as well as
in combination with MCP-1 led to a late enhanced
macrophage accumulation (7 d after occlusion; Figure
7A) possibly by further reducing already decreased early
NO bioavailability (12 h after occlusion; Figure 3).
Surprisingly, the L-NAME group did not show an
increased collateral proliferation, despite the increased
number of macrophages as compared to the PBS group.
It appears that if L-NAME inhibits the collateral NO
peak (occurring 24 h after occlusion; Figure 3) macro-
phages are not able to enhance collateral proliferation
(not even in the presence of MCP-1). One could specu-
late that NO is essential for the differentiation and local
proliferation of already migrated macrophages. The fact
that the total number of collaterals was reduced (Figure
7C) in the L-NAME group is most likely due to a vaso-
constrictive effect of L-NAME and in line with previous
reports by Mees at al. showing that the transient
decrease in collateral blood flow in eNOS knockout ani-
mals is mainly due to the inability to vasodilate [24].
Furthermore, it appears that MCP-1 somehow abolished
the vasoconstrictive effecto fL - N A M E( r e f l e c t e di na n
increased number of collaterals; Figure 7C). This finding
is rather unexpected because a direct vasodilatory effect
of MCP-1 has not, to our knowledge, been described
yet.
Our study highlights that collateral growth is a multi-
phase process with different distinct stages. Elevated
CBF/FSS and increased NO production appear to be
restricted to later phases of collateral growth. Thus, stu-
dies investigating the impact of an artificially elevated
FSS on collateral growth, for instance via construction
of an arterio-venous shunt, are capable of elucidating
certain mechanisms of collateral growth but will possi-
bly miss others. In this context, it is noteworthy that in
t h ef i r s ts t u d yi n v e s t i g a t i n gt h ee f f e c to fs h u n t i n go n
collateral growth, shunts were created 7 d after femoral
artery occlusion [6]. According to our findings, the
short period of low CBF/FSS and macrophage recruit-
m e n th a dl o n gp a s s e da tt h i st i m ep o i n t .F u r t h e r m o r e ,
several studies showed that the peak of macrophage
recruitment and proliferation occurred during the first
week after femoral artery occlusion and was followed by
a prolonged phase of vascular remodeling [1,2,28]. Thus,
the arterio-venous shunt in the study of Pipp et al.
probably enhanced and prolonged the remodeling phase
of collateral growth. At this time point, neither macro-
phage recruitment nor proliferation is very prominent
anymore [2,8,28]. The later extensive remodeling phase
of collateral growth rather appears to be driven by
migratory processes and possible further stimulation of
progenitor cells that are mainly vascular resident at this
time [25,29]. While a recent study failed to show an
effect of the small GTPase Rac2 on collateral growth
[30], Eitenmuller et al. were able to demonstrate that
the Rho-GTPase pathway was activated during arterio-
venous shunting of collateral vessels at the time of
femoral artery occlusion [15]. This pathway plays an
important role in migratory processes. L-NAME abol-
ished the positive effect of arterio-venous shunting on
collateral conductance. Unfortunately, neither macro-
phage accumulation nor collateral proliferation was
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Figure 7 A, Quantification of resident macrophage.( m a t u r e ,
ED2 positive) accumulation in vehicle (PBS), MCP-1, vehicle (PBS) +
L-NAME and MCP-1 + L-NAME treated animals 7 d after femoral
artery occlusion, macrophage score per collateral section, *p < 0.05
vs. PBS. B, Quantification of collateral proliferation in vehicle
(PBS), MCP-1, vehicle (PBS) + L-NAME and MCP-1 + L-NAME treated
animals 7 d after femoral artery occlusion, proliferative index, *p <
0.05 vs. MCP-1. C, Quantification of angiographically visible
collateral vessels in vehicle (PBS), MCP-1, vehicle (PBS) + L-NAME
and MCP-1 + L-NAME treated animals 7 d after femoral artery
occlusion, number of visible collaterals, *p < 0.03 vs. PBS, †p < 0.001
vs. MCP-1, ‡p < 0.001 vs. PBS + L-NAME.
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Page 9 of 11investigated in this study. Taken together, the findings
of Eitenmuller et al. and Pipp et al., in conjunction with
our data, suggest that arterio-venous shunting enhances
collateral conductance via prolongation and augmenta-
tion of the remodeling phase of collateral growth that
occurs after the initial phase characterized by vascular
proliferation and macrophage accumulation [1,28]. As
the results of our study do not contradict investigations
showing a dramatically increasing remodeling process of
collateral vessels after construction of an arterio-venous
shunt, they also do not contradict findings demonstrat-
ing the importance of the NO system in stem cell mobi-
lization during vascular growth, because our study
focuses on local kinetics in collateral vessels and not on
the bone marrow niche that may be subject to quite dif-
ferent kinetics at the same time [31]. Finally, the ques-
tion arises whether our model of an acute occlusion of
the femoral artery resembles the pathophysiological
situation encountered in human patients. In the human
heart, this certainly only pertains to the situation of an
acute myocardial infarction. In this setting, the kinetics
of collateral growth are indeed similar to the ones seen
in our model [32].
Limitations of study
The major limitation of our study is that we provide
data only on CBF and not on FSS (the main stimulus of
collateral growth). Collateral shear stress can be calcu-
lated by using the following equation assuming Newto-
nian fluid dynamics, if the collateral blood flow (Q),t h e
blood viscosity (h), and the internal radius of the collat-
eral vessel (R) are provided.
FSS
Q
R
=
××
×
4
3


The equation demonstrates that increased blood flow
will only directly result in increased FSS if blood viscos-
ity and the radius/diameter of the vessel remained the
same.
Our experimental set-up (with extended surgery) only
allowed us to measure temporal changes in collateral
blood flow velocities but not changes in collateral dia-
meter in the same animal at the same time. Obtaining
the collateral diameter is rather challenging as the main
collateral vessel is rather small (according to our data,
around 150 to 200 μm [1]) and it also must be obtained
very accurately because, according to the Hagen-Poi-
seuille law, a 10% change in radius alters FSS by
approximately 30% and a 20% change equates to 70%.
Although collateral diameters can be obtained (e.g. with
the use of MR angiographies), it was not feasible in our
study after all the applied surgical techniques. The level
of NOS expression can give a rather indirect hint to
how shear stress changes during arteriogenesis since
NOS expression is FSS dependent.
It furthermore might seem rather puzzling that we
measured NOS expression on one hand (Figure 1A) and
administered an NO donor on the other hand (Figure
1B). It is important to note that, as shown in Figure 1,
NOS expression measurements and administration of
NO donors (GTN) were performed in independent
experiments; specifically, NOS expression therefore was
never measured in the presence of an NO donor (GTN).
GTN was administered in order to reduce peripheral
resistance and to open up the ischemic microcirculation,
but certainly has several limitations. However, alterna-
tive substances such as selective resistance vessel vasodi-
lators did not seem to be suitable in our experimental
setting. For example, adenosine has a short life span and
had not, to our knowledge, been used in osmotic
pumps. Even if the GTN was given peripheral to the
collateral network (Figure 2) in a small dose, a low
degree of reflux into the collateral network cannot be
excluded. NO generated from GTN could also directly
affect collateral monocyte/macrophage adherence and
cell proliferation after entering the systemic circulation
and the collateral network. Nitrate tolerance normally
develops after 72 h of continuous high-dose exposure,
while we used low-dose administration up to a maxi-
mum of 72 h.
Because we focused on macrophages only, we could
have missed effects of other immune and inflammatory
cells on collateral proliferation. There is, for example,
strong evidence that CD4-positive lymphocytes provide
an arteriogenic effect by recruiting macrophages to the
site of active collateral growth [33].
Conclusions
We present, for the first time, direct evidence of natural
blood flow kinetics in collateral vessels after femoral
artery occlusion. According to our data, CBF as well as
NOS expression is initially reduced during arteriogen-
esis, allowing macrophages to accumulate and therewith
enhancing collateral proliferation. These results help
clarifying important questions concerning the arterio-
genesis hypothesis, in particular, the interplay of CBF/
FSS, NO, and macrophage recruitment.
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